Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis.

Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis.

BACKGROUND: Two antibiotic regimens are used commonly in Thailand for the initial treatment of severe melioidosis: ceftazidime in combination with trimethoprim-sulfamethoxazole (TMP-SMX) and ceftazidime monotherapy. It is not known whether TMP-SMX provides an additional benefit. METHODS: Two prospe...

Full description

Bibliographic Details
Main Authors:	Chierakul, W, Anunnatsiri, S, Short, J, Maharjan, B, Mootsikapun, P, Simpson, A, Limmathurotsakul, D, Cheng, A, Stepniewska, K, Newton, P, Chaowagul, W, White, N, Peacock, S, Day, N, Chetchotisakd, P
Format:	Journal article
Language:	English
Published:	2005

Similar Items

Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit
by: Chierakul, W, et al.
Published: (2007)

Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis.
by: Chaowagul, W, et al.
Published: (2005)

Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial.
by: Chetchotisakd, P, et al.
Published: (2014)

Trimethoprim-sulfamethoxazole versus trimethoprimsulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): A multicentre, double-blind, non-inferiority, randomised controlled trial
by: Chetchotisakd, P, et al.
Published: (2014)

Trimethoprim-sulfamethoxazole versus trimethoprimsulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): A multicentre, double-blind, non-inferiority, randomised controlled trial
by: Chetchotisakd, P, et al.
Published: (2014)

Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis.
by: Cheng, A, et al.
Published: (2009)

A comparison between 12 versus 20 weeks of trimethoprim-sulfamethoxazole as oral eradication treatment for melioidosis: an open-label, pragmatic, multicenter, non-inferiority, randomized controlled trial
by: Anunnatsiri, S, et al.
Published: (2020)

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei.
by: Wuthiekanun, V, et al.
Published: (2005)

Halving of mortality of severe melioidosis by ceftazidime.
by: White, N, et al.
Published: (1989)

A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis.
by: Chaowagul, W, et al.
Published: (1999)

Comparison of imipenem and ceftazidime as therapy for severe melioidosis.
by: Simpson, A, et al.
Published: (1999)

Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis.
by: Suputtamongkol, Y, et al.
Published: (1994)

Risk factors for recurrent melioidosis in northeast Thailand.
by: Limmathurotsakul, D, et al.
Published: (2006)

Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis.
by: Cheng, A, et al.
Published: (2008)

Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
by: Chuanqi Wei, et al.
Published: (2016-01-01)

Short report: Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis
by: Cheng, A, et al.
Published: (2008)

Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.
by: Angus, B, et al.
Published: (2000)

Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.
by: Angus, B, et al.
Published: (2000)

Increasing incidence of human melioidosis in Northeast Thailand.
by: Limmathurotsakul, D, et al.
Published: (2010)

Role and significance of quantitative urine cultures in diagnosis of melioidosis.
by: Limmathurotsakul, D, et al.
Published: (2005)

Patterns of organ involvement in recurrent melioidosis.
by: Limmathurotsakul, D, et al.
Published: (2009)

Rheumatological manifestations in patients with melioidosis.
by: Teparrakkul, P, et al.
Published: (2008)

Trimethoprim+Sulfamethoxazole Reduces Rates of Melioidosis in High-Risk Hemodialysis Patients
by: Sandawana William Majoni, et al.
Published: (2018-01-01)

Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei.
by: Dance, D, et al.
Published: (1991)

Short Report: Patterns of Organ Involvement in Recurrent Melioidosis
by: Limmathurotsakul, D, et al.
Published: (2009)

Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei.
by: Dance, D, et al.
Published: (2014)

Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection.
by: Sarovich, D, et al.
Published: (2012)

Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection
by: Sarovich DS, et al.
Published: (2012-08-01)

Variable presentation of neurological melioidosis in Northeast Thailand.
by: Limmathurotsakul, D, et al.
Published: (2007)

Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis (vol 49, pg 445, 2000)
by: Angus, B, et al.
Published: (2000)

Evaluation of treatment outcomes of intravenous ceftazidime as the intensive phase antimicrobial in melioidosis – a case series
by: A. N. KuruppuArachchi, et al.
Published: (2017-12-01)

Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei.
by: Chantratita, N, et al.
Published: (2011)

Pharmacokinetic and pharmacodynamic assessment of co-amoxiclav in the treatment of melioidosis.
by: Chierakul, W, et al.
Published: (2006)

Diabetes mellitus, insulin, and melioidosis in Thailand.
by: Simpson, A, et al.
Published: (2003)

Ceftazidime and cefotaxime--the clinician's choice.
by: Puthucheary, S.D., et al.
Published: (1989)

Rapid immunofluorescence microscopy for diagnosis of melioidosis.
by: Wuthiekanun, V, et al.
Published: (2005)

Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse.
by: Maharjan, B, et al.
Published: (2005)

Biofilm formation in trimethoprim/sulfamethoxazole-susceptible and trimethoprim/sulfamethoxazole-resistant uropathogenic Escherichia coli
by: Nitis Smanthong, et al.
Published: (2015-06-01)

Antibodies from patients with melioidosis recognize Burkholderia mallei but not Burkholderia thailandensis antigens in the indirect hemagglutination assay.
by: Tiyawisutsri, R, et al.
Published: (2005)

Short report: disease severity and outcome of melioidosis in HIV coinfected individuals.
by: Chierakul, W, et al.
Published: (2005)